PYX Resources: Achieving volume and diversification milestones. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
tkr what are people say on twitter about results? Are you referring to biosynex' results and therefore by association ours?
No there is definitely no reason to release results early however good they are, we are still in March. If and it's only an if, results through the first four months are so great as to warrant an upgrading of guidance for 2022, then that will be done on the 25th April. Personally i'm not expecting it and would be very happy to see strong enough figures to meet our current guidance.
Has reappeared in my vicinity and was doing a steady amount after all testing finished.
The 500 shares at c 226.5 was my buy but showing as a sell.
To be fair Cluelesshareboy Oxford Nanopore are also cash rich, they have far more cash on hand than we do, about £400m. That isn't through making enormous profits however, it's from a massive, massive IPO that raised over £500m.
The market is valuing Oxford Nanopore at about 8x cash and us at 1.5x cash currently. They're depleting their cash pile by over £100m a year and we are likely increasing ours.
The only explanation for Nanopore's sky high multiple is the potential of their tech - we know novacyt's own strength is their R&D, we know they have pioneering tech and products of their own... if they are able to market their innovations better and start commanding similar multiples then ncyt will easily command a £b+ valuation.
Surely if results are good as we hoped,this is going by reports from twitter/twatter,they should be released before the stated date app 25/4/22.DA has to get this sp going in the right direction and pronto,Some time next week would please many of us,cmon DA do the biss.
Sorry board..... Mr allmond likes bored.... Ltio.............
Sorry board..... Mr allmond likes bored
Covid testing companies launch own regulator after warnings of missleading adverts...... Operation directions lab21
Not so much over valued imo, more over played!
Seems, we wait until the next update, not long and probably get to shove more in isa's and sipps, which I thought we would not get chance to do!
Time for the morning crossword, as this is like watching paint dry but more boring lol
well it was said at the time that it was overvalued , but how can they get it so wrong ? Then on the other foot value cash rich , debt free , Ncyt so low
well at least we know why the bid was 225 at start so they could justify, 230 buys being red...
#itstinks !!!
Neither is the sp...
LSE platform not working properly
HC , ON CTDA :)
Surprised? It's loss making (a whopping £170m loss in 2021) and generates just £130m revenue yet still has a market cap of £3.3b after the fall!
Off subject , but was surprised to see Oxford nanopore share is slightly lower at £4.07 than its IPO price of £4.25, seems Boris cant even support those he even once championed
Yes Kaeren,pretty stupid now that the war is "ending" and markets went nuts for a bit ,of course it won't,just like this new varient,that won't end either.It was 120 years ago or so when "influenza" came to our attention and promoted no less than 5 pandemics worldwide.The world is a lot narrower now due to frequent air travel,so pandemics could become a feature to look forward to every 2/3 years,blimy!
Flu is approaching death figures each year which well match those attributable to co19, thank goodness Nova have a test,the symptoms of co19 match too.
I recently postulated that surgerys seriously consider buying a Q16 and kitting out a vented cupboard etc,nurses are on the up, the ones I meet are becoming highly skilled and the technical skills involved are not difficult.Looking back I recall the ch4 documentary on the testing machines dropping snotters all over the place!
A singular machine with a small bank of tests plus the opportunity to use hundreds of others that Nova make,opportunity knocks!
Gizmo, Mr Abensur looks to be in line for a large dividend payment on all those shares he owns in Biosynex.
There you go assuming again, nope, simply those that want to buy in at a price and sell out at a price and move on... Traders are patient and wait their entry and exit, unless they know of a sure fire alternative like Poly this morning rising from 246 to into the 3's
IMO There is far more to this o, than meets the normal layman's eye? If only we knew, but we dont, so the only other choice is wait, or sell, some cant wait, others will, lets face it, the % rate is still cr 4p so why not wait a while longer and indeed buy on dip if you think it dips far enough? dyor only my take... #neverassume although we all do :) way to much!
Biosynex about 25% up in month
Pretty crap traders if they are looking at this with the movements elsewhere today.
Unfortunately that is not true either. The patient are the ones losing money, the traders (who I assume you are calling the impatient) are the ones making the money.
In that case, it is just a case of doing a Warren Buffet and play the waiting game, where the patient, take money from the impatient... assuming time is not an issue... #yawn :)
Every trade is recorded by mm's,they automatically avoid selling at a loss and may, during high demand,simply run out of stock,unless the stock is being heavily barge poled they always make a profit on the spread.That's how it works.
Val, I'm not convinced every buy needs a sell. I see the MM's as kind of a shop keeper. They accept your sells and pass them on to a buyer (at a slightly higher price) when one turns up. If there isn't a buyer they will hold until one turns up. They will have orders to fill. I believe it is possible for MM's to lose out during moments of sudden high drops and spikes hence you get the 'NT to sell', basically during a NT to sell, even the MM's don't want your stock. MM's won't keep lots of stock but it is essential for them to do their job imo. I have no first hand knowledge of this but just the way I see it